U.S. Approves Drug Co-Developed by Ugandan Doctor

The U.S. Food and Drug Administration has announced its approval of the Moxidectin 8mg Oral research project which Ugandian health professional Amos Nyathirombo co-founded. The six-year research led by the WHO will help with the treatment of River Blindness in patients 12 years of age and older.

Dr Amos Nyathirombo (left) examines a patient at Gulu Regional Referral Hospital early this year.

See What Everyone is Watching